Anti-Frostbite Effects of Prunus Tomentosa Thunb Total Flavone

Abstract

The aim of this study is to assess the influence of Prunus Tomentosa Thunb Total Flavone (PTTTF) on rabbits' frostbitten ears and on expressions of Matrix Metalloproteinase (MMP-9) in mouse frostbitten tissues and IL-1β in mouse Peripheral Blood Mononuclear Cells (PBMCs). Twelve New Zealand rabbits were randomly divided into two groups, both ears of each rabbit were frostbitten by liquid nitrogen. PTTTF and triamcinolone acetonide acetate ointment (TAAO) were spread on the left ear for 7 days, and the right ear was not treated as control. Therapeutic effects of the drugs and the pathological changes were observed. Drugs (PTTTF and TAAO) were prophylactically spread on the skin of the paws of mice for 5 days. After paw frostbitten models were established, the agents were consecutively spread for another 2 days. Expressions of MMP-9 in frostbitten tissues and IL-1β in PBMCs were respectively detected by the immunohistochemical method and RT-PCR. Compared with controls, four days later, the swelling inhibiting rate of PTTTF was 26.84%, and was 32.52% seven days later. The therapeutic effect of PTTTF was better than that of TAAO. Pathological changes of PTTTF group showed the effusion of a small quantity of neutrophil granulocytes and the tissue dropsy was not obvious. Expressions of both MMP-9 and IL-1β were significantly decreased in PTTTF group compared with those in model control group. There was no significant difference in expressions of MMP-9 and IL-1β between PTTTF group and TAAO group. We concluded that PTTTF produced a significant therapeutic effect on the frostbite of the rabbits' ears. PTTTF could inhibit expressions of MMP-9 in frostbite tissues and IL-1β in PBMCs to relieve the frostbite inflammation.

Keywords

PTTTF inflammation and immunoregulation Chinese traditional medicine MMP-9 IL-1β

References

Huiying

Zhimou

Zhengyu

. The establishment of rabbit frostbite model. Shanghai Laboratory Animal Science 2003; 23:51–52.

Bantim Felício

C Iana

Italo Maia

S Daniel

Matos de Andrade

C Geanne

. Topically Applied Diterpenoids from Egletes viscosa (Asteraceae) Attenuate the Dermal Inflammation in Mouse Ear Induced by Tetradecanoylphorbol 13-Acetate- and Oxazolone. Biol Pharm Bull 2008; 31:1511–16.

Andre

John

Sushma

. p53 mutation in adenocarcinoma arising in retrorectal cyst hamartoma (Tailgut Cyst): Report of 2 Cases - an immunohistochemistry/immunoperoxidase study. Arch Pathol Lab Med 2001; 125:1361–64.

Sands

. Epidemiology of sepsis syndrome in 8 academic medical centers. AMA 1997; 278:234–40.

Angus

. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–10.

Martin

. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546–54.

Gibson

Rothwell

Le Feuvre

. CNS injury: The role of the cytokine IL-1. Vet J 2004; 168: 230–37.

Kane

Jensen

Grehan

Whitehead

Bresnihan

Fitzgerald

. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pan-nus junction. J Rheumatol 2004; 31:1274–80.

Foxwell

Bondeson

Brennan

Feldmann

. Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: Evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production. Ann Rheum Dis 2000; 59:154–59.

10.

Koenders

Kolls

Uppers-Walgreen

. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3,9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 2005; 52:3239–47.

11.

Gayle

Vaday

Hershkoviz . Fibronectin bound TNF-α stimulates monocyte matrix metalloproteinase-9 expression and regulate Chemotaxis. J Leuko Bio 2000; 68:737–47.

12.

Lobmunn

Ambrosch

Schultz

. Expression of matrixmetalloprotienases and their inhibitors in the wounds of diabetic and non-diabetic Patients. Diabetologia 2002; 45:1011–16.

13.

Fredeinok

. Martrix metalloproteinase and their inhibitor in connective tissue remodeling. FASEB J 1991; 5:2145–54.

14.

Yoshihara

Nakamara

Obatak . Martrix meatlloproeinase and tissue inhibitor of metalloprot einase in synovial fluids from patients with RA or osteoarthritis. Ann Rheum Dis 2000; 59:455–61.